Faculty By Divisions

Hasan Sonmezturk, M.D.


Dr. Sonmezturk was born in Nicosia, Cyprus in 1975. He graduated from Marmara University School of Medicine in Istanbul, Turkey, and then moved to US for his residency training at University of Arkansas College of Medicine (UAMS). He initially practiced as a general neurologist then completed a two-year clinical neurophysiology and epilepsy fellowship at Vanderbilt University Medical Center where he served as chief fellow during the second year. After completing his fellowship he joined the faculty at Vanderbilt University Department of Neurology as Assistant Professor of Neurology since 2011. Dr. Sonmezturk received "residents teaching award" three years in a raw for the academic years 2011-2012,  2012-2013 and 2013-2014. His other awards include "best fellow award" for 2009-2010 academic year. Dr. Sonmezturk maintains licensure in Tennessee, and is triple board certified in Neurology (2007), Clinical Neurophysiology (2011) and Epilepsy (2013).  


1-Sonmezturk HH Arain AM, Paolicchi JM, Abou-Khalil BW. Similar response to anti-epileptic medications among epileptic siblings. Epilepsy Res. 2011 Oct 24. [Epub ahead of print]
2-Morgan VL, Rogers BP, Sonmezturk HH, Gore JC, Abou-Khalil B. Cross hippocampal influence in mesial temporal lobe epilepsy measured with high temporal resolution functional magnetic resonance imaging. Epilepsia. 2011 Sep;52(9):1741-9.
3-Sonmezturk HH, Morgan V, Abou-Khalil B. Focal seizure propagation illustrated by fMRI. Epileptic Disord. 2011 Mar;13(1):92-5.
4- Zubair S, Patton T, Smithson K, Sonmezturk HH, Arain A, Abou-Khalil B. Propofol withdrawal seizures: non-epileptic nature of seizures in a patient with recently controlled status epilepticus. Epileptic Disord. 2011 Mar;13(1):107-10
5- Kirkpatrick MP, Clarke CD, Sonmezturk HH, Abou-Khalil B. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav. 2011 Feb;20(2):392-4. Epub 2010 Dec 28
6-Sonmezturk HH, Azar NJ, Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures. Journal of Central Nervous System Disease 2011:3 17-25